Biocon Ltd on Monday said it has launched its diabetes and chronic, Liraglutide, in the Netherlands through its distribution partner, Pharmamedic BV.   The drug-device combination will be marketed in ...
Biocon launches Liraglutide injection (Diavorin & Vobexoryn) for diabetes and weight management in the Netherlands with ...